IBEX Q2 revenue $140.7M (+6.1% YoY); raises FY guidance; adjusted EPS $0.59

IBEX Ltd

2025-Q2 EPS reported $1.00 vs consensus $0.71 ▲ beat (+40.1%)

Q2 revenue $140.7M (+6.1% YoY); net income $9.3M (+52.6%); diluted EPS $0.57 vs $0.33 a year ago.
Adjusted EPS $0.59 (+36% YoY); adjusted EBITDA $16.5M (+15.4%); margin 11.8% vs 10.8%.
Raised FY2025 revenue guidance to $525-535M (from $515-525M); adjusted EBITDA guidance $68-69M.
Repurchased 3.6M shares from TRGI for $70M, eliminating controlled company status.
HealthTech (+31.2%) and Travel/T&L (+16.7%) drove growth; FinTech declined 14.7%.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.